LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
YETI Holdings
YETI
Precision Drilling
PDS
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 12.18%-1.35M | 31.04%-955.32K | 54.64%-1.14M | 42.73%-6.64M | 53.98%-1.2M | 47.87%-1.54M | 62.54%-1.39M | -7.87%-2.51M | -83.92%-11.6M | 9.62%-2.62M |
Net income from continuing operations | -262.82%-8.08M | -36.15%-3.36M | 19.14%-1.9M | 40.18%-10.47M | 45.51%-3.43M | 45.38%-2.23M | 36.25%-2.47M | 28.10%-2.35M | -86.56%-17.51M | -72.16%-6.29M |
Operating gains losses | ---- | ---- | ---- | --291K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 3.86%347.8K | 2.49%341.63K | 7.51%352.76K | -22.99%1.36M | -25.60%366.42K | -10.74%334.87K | -40.93%333.33K | -2.82%328.13K | 102.74%1.77M | 73.93%492.51K |
Other non cash items | 729.87%5.67M | 221.86%1.83M | 255.36%682.52K | 107.35%2.93M | 456.07%1.48M | 150.36%682.8K | -33.74%569.89K | 1,412.05%192.06K | 1,245.04%1.41M | 504.80%266.81K |
Change In working capital | 24.58%-251.06K | 161.22%230.04K | 61.07%-276.3K | -307.49%-977.26K | -578.06%-22.73K | -172.34%-332.91K | 110.79%88.06K | -736.66%-709.69K | -361.39%-239.82K | 103.33%4.75K |
-Change in receivables | 118.20%58.8K | -21.05%-121.25K | -55.45%-341.58K | 26.03%-509.21K | 218.08%133.79K | -302.15%-323.11K | 83.35%-100.16K | -64.72%-219.74K | -1,008.19%-688.43K | -458.54%-113.31K |
-Change in inventory | 101.52%805 | 220.86%50.47K | -484.60%-19.91K | 116.39%17.19K | 459.23%49.21K | -285.02%-52.93K | 116.36%15.73K | 121.90%5.18K | -1,883.83%-104.91K | -23.64%-13.7K |
-Change in prepaid assets | 107.81%7.37K | 272.65%308.35K | -1,567.18%-287.29K | 175.83%112.12K | 304.61%140.97K | -123.60%-94.37K | 118.20%82.75K | 28.94%-17.23K | -112.03%-147.85K | 21.10%-68.9K |
-Change in payables and accrued expense | -217.40%-233.77K | -50.00%75.34K | 201.35%438.69K | -150.03%-338.78K | -225.03%-255.74K | 186.69%199.13K | -66.17%150.67K | -268.49%-432.84K | 644.41%677.11K | 369.23%204.53K |
-Change in other current liabilities | -36.75%-84.27K | -36.03%-82.87K | -46.95%-66.21K | -1,166.74%-258.58K | -2,247.66%-90.97K | -160.66%-61.63K | ---60.92K | ---45.06K | --24.24K | ---3.88K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 12.18%-1.35M | 31.04%-955.32K | 54.64%-1.14M | 42.73%-6.64M | 53.98%-1.2M | 47.87%-1.54M | 62.54%-1.39M | -7.87%-2.51M | -83.92%-11.6M | 9.62%-2.62M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -26.89K | -101.72%-17.15K | -101.01%-11.67K | 189.39%2.17M | -93.04%21.12K | 0 | 180.06%998.69K | 172.26%1.15M | 54.91%-2.43M | 106.63%303.22K |
Net PPE purchase and sale | ---26.89K | --0 | ---11.67K | 101.25%40.62K | 229.92%21.12K | --0 | 101.11%19.5K | --0 | -63.07%-3.26M | 98.63%-16.26K |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---321.25K | --0 |
Net investment purchase and sale | --0 | --0 | --0 | 85.04%2.13M | --0 | --0 | 95.17%979.19K | --1.15M | 134.18%1.15M | 109.49%319.47K |
Net other investing changes | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---26.89K | -101.72%-17.15K | -101.01%-11.67K | 189.39%2.17M | -93.04%21.12K | --0 | 180.06%998.69K | 172.26%1.15M | 54.91%-2.43M | 106.63%303.22K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 224.04%1.9M | -0.87%1.23M | 587.40%973.44K | 3.92%2.63M | 606.43%1M | 1,871.68%586.79K | -29.82%1.24M | -121.40%-199.72K | -89.60%2.53M | -152.70%-198.32K |
Net issuance payments of debt | -14.54%501.46K | -0.87%1.23M | 587.40%973.44K | 3.92%2.63M | 606.43%1M | 1,871.68%586.79K | -29.82%1.24M | -121.40%-199.72K | 354.86%2.53M | -152.70%-198.32K |
Net common stock issuance | --0 | --0 | --0 | --25.31K | --0 | --0 | --0 | --25.31K | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---25.31K | --0 | --0 | --0 | ---25.31K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 224.04%1.9M | -0.87%1.23M | 587.40%973.44K | 3.92%2.63M | 606.43%1M | 1,871.68%586.79K | -29.82%1.24M | -121.40%-199.72K | -89.60%2.53M | -152.70%-198.32K |
Net cash flow | ||||||||||
Beginning cash position | -77.43%306.81K | -90.37%48.61K | -89.02%226.99K | -84.76%2.07M | -91.15%405.23K | -81.62%1.36M | -95.23%504.58K | -84.76%2.07M | 1,436.04%13.56M | -77.83%4.58M |
Current changes in cash | 154.65%521.37K | -69.79%258.2K | 88.58%-178.37K | 83.99%-1.84M | 92.90%-178.25K | 66.13%-954.1K | 126.91%854.75K | 47.74%-1.56M | -190.66%-11.49M | 64.59%-2.51M |
End cash Position | 104.37%828.19K | -77.43%306.81K | -90.37%48.61K | -89.02%226.99K | -89.02%226.99K | -91.15%405.23K | -81.62%1.36M | -95.23%504.58K | -84.76%2.07M | -84.76%2.07M |
Free cash flow | 10.44%-1.38M | 31.04%-955.32K | 54.17%-1.15M | 55.29%-6.64M | 54.26%-1.2M | 51.50%-1.54M | 74.57%-1.39M | 30.21%-2.51M | -78.49%-14.86M | 35.78%-2.63M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |